Peter Lucks
Director Sales Europe at Phagenesis Ltd- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Reinhard Krickl
Peter is hungry: hungry to learn, hungry to develop markets for innovative treatment options, hungry to get it right. That makes him an invaluable sparing partner and a restless researcher of what's really going on in a specific care segment. He is able to analyse complex scientific and business situations and derive a strategy, but also loves being in the field as perfect liaison partner with clinicians and opinion leaders. Through his executive education, I am pleased to see how Peter has strategically developed his leadership skills. He will certainly continue to grow into more senior leadership positions. I will continue to value his profound knowledge around the medical device industry and feel fortunate to have him in my network.
Hanne Mai
In my role as Program Director for Kellogg-WHU Executive MBA program I was working with Peter during the 2 years of his EMBA studies and I don’t want to miss this enriching experience. Not only finished Peter his EMBA studies as best of his class, he also took the important leadership role of the class speaker and gave his full commitment to this role. He was the voice of his cohort towards the program management, recognizing interpersonal relationships and leveraging strengths for positive results. He also became an invaluable ambassador of the program. Peter works collaboratively with others, demonstrating commitment to achieve group objectives. He has a strong desire to help and support peers in a way that best meets everyone’s actual needs. He acts in a proactive way by taking action and is always seeking to improve both results and personal relationships!
Reinhard Krickl
Peter is hungry: hungry to learn, hungry to develop markets for innovative treatment options, hungry to get it right. That makes him an invaluable sparing partner and a restless researcher of what's really going on in a specific care segment. He is able to analyse complex scientific and business situations and derive a strategy, but also loves being in the field as perfect liaison partner with clinicians and opinion leaders. Through his executive education, I am pleased to see how Peter has strategically developed his leadership skills. He will certainly continue to grow into more senior leadership positions. I will continue to value his profound knowledge around the medical device industry and feel fortunate to have him in my network.
Hanne Mai
In my role as Program Director for Kellogg-WHU Executive MBA program I was working with Peter during the 2 years of his EMBA studies and I don’t want to miss this enriching experience. Not only finished Peter his EMBA studies as best of his class, he also took the important leadership role of the class speaker and gave his full commitment to this role. He was the voice of his cohort towards the program management, recognizing interpersonal relationships and leveraging strengths for positive results. He also became an invaluable ambassador of the program. Peter works collaboratively with others, demonstrating commitment to achieve group objectives. He has a strong desire to help and support peers in a way that best meets everyone’s actual needs. He acts in a proactive way by taking action and is always seeking to improve both results and personal relationships!
Reinhard Krickl
Peter is hungry: hungry to learn, hungry to develop markets for innovative treatment options, hungry to get it right. That makes him an invaluable sparing partner and a restless researcher of what's really going on in a specific care segment. He is able to analyse complex scientific and business situations and derive a strategy, but also loves being in the field as perfect liaison partner with clinicians and opinion leaders. Through his executive education, I am pleased to see how Peter has strategically developed his leadership skills. He will certainly continue to grow into more senior leadership positions. I will continue to value his profound knowledge around the medical device industry and feel fortunate to have him in my network.
Hanne Mai
In my role as Program Director for Kellogg-WHU Executive MBA program I was working with Peter during the 2 years of his EMBA studies and I don’t want to miss this enriching experience. Not only finished Peter his EMBA studies as best of his class, he also took the important leadership role of the class speaker and gave his full commitment to this role. He was the voice of his cohort towards the program management, recognizing interpersonal relationships and leveraging strengths for positive results. He also became an invaluable ambassador of the program. Peter works collaboratively with others, demonstrating commitment to achieve group objectives. He has a strong desire to help and support peers in a way that best meets everyone’s actual needs. He acts in a proactive way by taking action and is always seeking to improve both results and personal relationships!
Reinhard Krickl
Peter is hungry: hungry to learn, hungry to develop markets for innovative treatment options, hungry to get it right. That makes him an invaluable sparing partner and a restless researcher of what's really going on in a specific care segment. He is able to analyse complex scientific and business situations and derive a strategy, but also loves being in the field as perfect liaison partner with clinicians and opinion leaders. Through his executive education, I am pleased to see how Peter has strategically developed his leadership skills. He will certainly continue to grow into more senior leadership positions. I will continue to value his profound knowledge around the medical device industry and feel fortunate to have him in my network.
Hanne Mai
In my role as Program Director for Kellogg-WHU Executive MBA program I was working with Peter during the 2 years of his EMBA studies and I don’t want to miss this enriching experience. Not only finished Peter his EMBA studies as best of his class, he also took the important leadership role of the class speaker and gave his full commitment to this role. He was the voice of his cohort towards the program management, recognizing interpersonal relationships and leveraging strengths for positive results. He also became an invaluable ambassador of the program. Peter works collaboratively with others, demonstrating commitment to achieve group objectives. He has a strong desire to help and support peers in a way that best meets everyone’s actual needs. He acts in a proactive way by taking action and is always seeking to improve both results and personal relationships!
Experience
-
Phagenesis Ltd
-
United Kingdom
-
Medical Device
-
1 - 100 Employee
-
Director Sales Europe
-
Aug 2022 - Present
Manage commercial efforts in Europe to drive growth of pharyngeal electrical stimulation (PES) using the Phagenyx neurostimulation system to treat neurogenic dysphagia. Manage commercial efforts in Europe to drive growth of pharyngeal electrical stimulation (PES) using the Phagenyx neurostimulation system to treat neurogenic dysphagia.
-
-
-
Inari Medical
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Country Manager Germany - Clinical Education Manager Europe
-
Aug 2020 - Aug 2022
Built the market for two paradigm-changing interventional technologies in the venous thromboembolism field from the ground up - FlowTriever for pulmonary embolism and ClotTriever for deep-vein thrombosis. Built the market for two paradigm-changing interventional technologies in the venous thromboembolism field from the ground up - FlowTriever for pulmonary embolism and ClotTriever for deep-vein thrombosis.
-
-
-
Nuvaira, Inc.
-
United States
-
Medical Device
-
1 - 100 Employee
-
Market Development Manager DACH
-
Dec 2019 - Jul 2020
Develop the DACH market for an innovative interventional treatment for COPD patients - dNerva Lung Denervation; oranization reduced due to Covid pandemic Develop the DACH market for an innovative interventional treatment for COPD patients - dNerva Lung Denervation; oranization reduced due to Covid pandemic
-
-
-
Johnson & Johnson
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Account Manager - Sales + Clinical Development Manager - Country Manager Germany
-
Dec 2016 - Nov 2019
Neuravi acquired by Johnson & Johnson - Jump-started sales for a new stent retriever Embotrap in Germany ; built market development strategy; hired a high-performance team of Clinical Development Managers to drive clinical knowledge around stroke; managed the integration of stroke product portfolios of Neuravi and JnJ into new brand Cerenovus; lead sales and marketing efforts in Germany; developed the German team to 10 members Neuravi acquired by Johnson & Johnson - Jump-started sales for a new stent retriever Embotrap in Germany ; built market development strategy; hired a high-performance team of Clinical Development Managers to drive clinical knowledge around stroke; managed the integration of stroke product portfolios of Neuravi and JnJ into new brand Cerenovus; lead sales and marketing efforts in Germany; developed the German team to 10 members
-
-
-
Medtronic
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
District Sales Manager Neurovascular
-
May 2016 - Nov 2016
Lead the sales team for Southern Germany. Lead the sales team for Southern Germany.
-
-
-
Elixir Medical Corporation
-
United States
-
Medical Device
-
1 - 100 Employee
-
Account Manager - Market Development Manager
-
Dec 2013 - Apr 2016
Started and drove sales and market development for a ground-breaking new interventional coronary treatment - bioresorbable scaffold DESolve Started and drove sales and market development for a ground-breaking new interventional coronary treatment - bioresorbable scaffold DESolve
-
-
-
Medtronic
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Therapy Sales Specialist
-
Oct 2012 - Nov 2013
Developed key accounts for an innovative interventional treatment for therapy-refractory hypertension patients - renal denervation Developed key accounts for an innovative interventional treatment for therapy-refractory hypertension patients - renal denervation
-
-
-
Boston Scientific
-
United States
-
Medical Equipment Manufacturing
-
700 & Above Employee
-
Quality Manager - Sales Representative
-
Aug 2008 - Sep 2012
Quality and Regulatory management for the DACH organization - Account management Interventional Cardiology Quality and Regulatory management for the DACH organization - Account management Interventional Cardiology
-
-
-
Parexel
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Clinical Research Associate
-
Sep 2007 - Jul 2008
Monitoring of clinical phase III and IV trials Monitoring of clinical phase III and IV trials
-
-
Education
-
2017 - 2019
Kellogg-WHU Executive MBA
Global Executive Master of Business Administration - MBA -
2001 - 2007
Johann Wolfgang Goethe-Universität Frankfurt am Main
Diploma, Molecular Biology -
2005 - 2006
University of Massachusetts Boston
Fulbright Scholar -
1999 - 2001
Audi AG
Business Apprenticeship
Community
